In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc

Journal of Pathology

Volumn 213, Issue 1, 2007, Pages 21-26

  Jones, M ^a   Peden, A H ^a   Prowse, C V ^b   Groner A ^c   Manson, J C ^d   Turner, M L ^e   Ironside, J W ^a   MacGregor, I R ^b   Head, M W ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c CSL BEHRING GMBH   (Germany)

^d AFRC & MRC Neuropathogenesis Unit   (United Kingdom)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Brain; Conformation dependent immunoassay; Platelets; PRNP codon 129 polymorphism; Protein misfolding cyclic amplification; vCJD

Indexed keywords

PRION PROTEIN; PROTEINASE K;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IN VITRO STUDY; MOUSE; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN POLYMORPHISM; PROTEIN SYNTHESIS; RISK ASSESSMENT; SYMPTOM; THROMBOCYTE; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; BLOOD PLATELETS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CODON; CREUTZFELDT-JAKOB SYNDROME; GENOTYPE; HUMANS; IMMUNOASSAY; MICE; MICE, TRANSGENIC; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION; PROTEIN FOLDING; PRPSC PROTEINS;

EID: 34548394607     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2204     Document Type: Article

References (28)

1. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro, K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
2. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.
3. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-421.
4. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-529.
5. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368:2061-2067.
6. HPA Press Statement 2007; Fourth case of variant CID infection associated with blood transfusion: www.hpa.org.uk/hpa/news/article/ press_releases/2007/070118_vCJD.htm.
7. Clarke P, Will RG, Ghani AG. Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK? J R Soc Interface 2007;[DOI: 10.1098/rsif.2007.0216].
8. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004;203:733-739.
9. Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, Le Grice M, et al. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Br Med J 2006;332:1186-1188.
10. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-13383.
11. Soto C, Saborio GP, Anderes L. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci 2002;25:390-394.
12. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001;411:810-813.
13. Castilla J, Saa P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell 2005;121:195-206.
14. Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, et al. Cell-free formation of misfolded prion protein with authentic prion infectivity. Proc Natl Acad Sci USA 2006; 103:15818-15823.
15. Soto C, Anderes L, Suardi S, Cardone F, Castilla J, Frossard MJ, et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 2005;579:638-642.
16. Saa P, Castilla J, Soto C. Presymptomatic detection of prions in blood. Science 2006;313:92-94.
17. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006;5:393-398.
18. Jones M, Head MW, Connolly JG, Farquhar CF, Hornsey VS, Pepper DS, et al. Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activation. Biochem Biophys Res Commun 2005;335:48-56.
19. Sc in skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 2006; 168:927-935.
20. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998;4:1157-1165.
21. Bellon A, Seyfert-Brandt W, Lang W, Baron H, Gröner A, Vey M. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J Gen Virol 2003; 84:1921-1925.
22. Saa P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 2006;281:35245-35252.
23. Asano M, Mohri S, Ironside JW, Ito M, Tamaoki N, Kitamoto T. vCJD prion acquires altered virulence through trans-species infection. Biochem Biophys Res Commun 2006;342:293-299.
24. Yakovleva O, Janiak A, McKenzie C, McShane L, Brown P, Cervenakova L. Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice. Transfusion 2004; 44:1700-1705.
25. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, et al. Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005;102:3501-3506.
26. Sc fraction. Biochemistry 2006; 45:15710-15717.
27. Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-180.
28. Holada K, Glierova H, Simak J, Vostal JG. Expression of cellular prion protein on platelets from patients with gray platelet or Hermansky-Pudlak syndrome and the protein's association with α-granules. Haematologica 2006;91:1126-1129.